# Novo Nordisk A/S has teamed up with OpenAI to use AI to speed up drug development.

*biotech · news · 2026-04-14 · SiliconANGLE News*

## Key points

- OpenAI will embed its intelligent agents across Novo Nordisk's entire drug development and distribution workflows.
- Novo Nordisk will access OpenAI’s most advanced frontier models to analyze massive biological datasets.
- The partnership includes direct AI training for Novo Nordisk employees to boost company-wide AI literacy.
- AI will be used to simulate lab experiments, predicting drug efficacy before physical samples are created.
- A strict data governance framework with human oversight will be established to ensure ethical AI use.

**Companies:** OpenAI Group PBC, Novo Nordisk A/S
**Countries:** United States, Denmark

[Read the full story on SiliconANGLE News](https://siliconangle.com/2026/04/14/openai-partners-novo-nordisk-accelerate-drug-discovery-delivery/)

---

Canonical: https://newsio.io/n/63931a05-6f85-4d61-8b9f-fe47c7f87126/novo-nordisk-as-has-teamed-up-with-openai-to-use-ai-to-speed-up-drug-development
Summarized by Newsio from SiliconANGLE News. https://newsio.io/how-it-works